Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Andrew Leech
Managing Paediatric Anxiety in General Practice
Dr Terri Foran
Non-Hormonal & Hormonal Options for Hot Flushes
Dr Adam Nelson
Why is LDL Control Important?
Dr Anita Munoz
Muscle Health in Chronic Disease: A Practical Guide for GPs
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
